Patents by Inventor Alan Hayter

Alan Hayter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9833181
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: December 5, 2017
    Assignee: Abbot Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Publication number: 20170340250
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: August 19, 2017
    Publication date: November 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Patent number: 9814416
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: November 14, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: 9801577
    Abstract: Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present disclosure include features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect are provided. Additional features are disclosed.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Patent number: 9804150
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 9801571
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Gary Alan Hayter
  • Patent number: 9804148
    Abstract: In particular embodiments, methods, devices and systems including calibrating analyte data associated with a monitored analyte level received from an analyte sensor based on a reference measurement, determining a lag time constant associated with the calibrated analyte data, and performing lag correction of the calibrated analyte data based on the determined time lag constant are disclosed.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: October 31, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Patent number: 9797880
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: October 24, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger
  • Publication number: 20170274144
    Abstract: Method of monitoring a control operation of a medication delivery system, determining whether a signal level received from an analyte sensor is associated with a fault condition and a potential fault condition, and adjusting a medication delivery rate executed by the control operation when it is determined that the signal level from the analyte sensor is associated with one of the fault condition or the potential fault condition, where the medication delivery rate is adjusted to a first predetermined range when the signal level is associated with the fault condition, and adjusted to a second predetermined range when the signal level is associated with the potential fault condition is provided. Devices, systems and kits for implementing the afore-mentioned method are also provided.
    Type: Application
    Filed: February 20, 2017
    Publication date: September 28, 2017
    Applicant: Abbot Diabetes Care Inc.
    Inventor: Gary Alan Hayter
  • Patent number: 9770211
    Abstract: Methods and devices and systems for determining an analyte value are disclosed.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: September 26, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman
  • Publication number: 20170265790
    Abstract: Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present disclosure include features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect are provided. Additional features are disclosed.
    Type: Application
    Filed: June 7, 2017
    Publication date: September 21, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Publication number: 20170266380
    Abstract: Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 21, 2017
    Inventors: Mark Kent Sloan, Gary Alan Hayter
  • Patent number: 9743872
    Abstract: Methods, devices, and kits are provided for mitigating single point failure of at least one device in an analyte monitoring system.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: August 29, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Marc Barry Taub
  • Patent number: 9737249
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: August 22, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Kenneth J. Doniger
  • Patent number: 9730623
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: August 15, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20170224258
    Abstract: Methods and apparatuses for determining an analyte value are disclosed.
    Type: Application
    Filed: April 21, 2017
    Publication date: August 10, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman, Kenneth J. Doniger, John Charles Mazza
  • Patent number: 9721063
    Abstract: Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system.
    Type: Grant
    Filed: March 9, 2016
    Date of Patent: August 1, 2017
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Andrew H. Naegeli
  • Publication number: 20170193184
    Abstract: Method and system including displaying a first representation of a medication treatment parameter profile, displaying a first representation of a physiological profile associated with the medication treatment parameter profile, detecting a modification to a segment of the medication treatment parameter profile, displaying a modified representation of the medication treatment parameter profile and the physiological profile based on the detected modification to the segment of the medication treatment parameter profile, modifying an attribute of the first representation of the medication treatment parameter profile, and modifying an attribute of the first representation of the physiological profile are provided.
    Type: Application
    Filed: March 24, 2017
    Publication date: July 6, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Timothy Christian Dunn
  • Publication number: 20170188909
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: March 16, 2017
    Publication date: July 6, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20170188908
    Abstract: Methods and systems for providing continuous analyte monitoring including in vivo sensors that do not require any user calibration during in vivo use are provided. Also provided are methods and devices including continuous analyte monitoring systems that include in vivo sensors which do not require any system executed calibration or which do not require any factory based calibration, and which exhibit stable sensor sensitivity characteristics. Methods of manufacturing the no calibration sensors and post manufacturing packaging and storage techniques are also provided.
    Type: Application
    Filed: March 16, 2017
    Publication date: July 6, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Christopher Allen Thomas, Geoffrey V. McGarraugh, Gary Alan Hayter